+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

2019 Perennial Allergic Rhinitis Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

  • ID: 4768067
  • Report
  • 286 pages
  • VPA Research
1 of 4

FEATURED COMPANIES

  • AstraZeneca Plc
  • Cipla Ltd
  • GlaxoSmithKline Plc
  • Merck & Co Inc
  • Novartis AG
  • Sanofi
  • MORE
The global clinical trial report- “2019 Perennial Allergic Rhinitis Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Perennial Allergic Rhinitis. It presents in-depth analysis of Perennial Allergic Rhinitis clinical trials across markets and companies. The research work is for providing complete understanding into trends in Perennial Allergic Rhinitis.

The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.

It also segments the Perennial Allergic Rhinitis clinical trials by:
  • Current Trial Status
  • Type of the trial
  • Sponsor Type
  • Enrollment Trends
  • Region
  • Countries
  • Trial Phase
The report also identifies the potential drug candidates under development for treatment of Perennial Allergic Rhinitis

The research work is prepared through extensive and continuous research on Perennial Allergic Rhinitis trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

Report Scope and Coverage:
  • All major trials from 2010 to 2019 and planned trials are included in the report scope.
  • Drug candidates currently being researched for administering Perennial Allergic Rhinitis patients are identified
  • The report includes panorama of Perennial Allergic Rhinitis clinical trials across the globe
  • Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided
  • Companies and universities focusing on Perennial Allergic Rhinitis clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)
  • Average Enrollment number, insights into enrollment trends, company wise enrollment are included
  • Both interventional and observational studies are analyzed
  • News and latest developments for the past one year are presented in the report
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • AstraZeneca Plc
  • Cipla Ltd
  • GlaxoSmithKline Plc
  • Merck & Co Inc
  • Novartis AG
  • Sanofi
  • MORE
1.1 List of Figures
1.2 List of Tables

2. Executive Summary
2.1 Perennial Allergic Rhinitis Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
2.2.1 Perennial Allergic Rhinitis Clinical Trials by Region
2.2.2 Average Enrollment of Perennial Allergic Rhinitis Clinical Trials
2.2.3 Companies participating in Trials
2.2.4 Drugs under Study for Perennial Allergic Rhinitis Treatment, 2019

3. Region wise Perennial Allergic Rhinitis Clinical Trials
3.1 Asia Pacific Perennial Allergic Rhinitis Clinical Trials by Country
3.2 Europe Perennial Allergic Rhinitis Clinical Trials by Country
3.3 North America Perennial Allergic Rhinitis Clinical Trials by Country
3.4 Middle East and Africa Perennial Allergic Rhinitis Clinical Trials by Country
3.5 South and Central America Perennial Allergic Rhinitis Clinical Trials by Country

4. Perennial Allergic Rhinitis Clinical Trial Trends
4.1 Start Year wise Perennial Allergic Rhinitis Clinical Trials
4.2 Phase wise Perennial Allergic Rhinitis Clinical Trials
4.3 Trial Status wise Perennial Allergic Rhinitis Clinical Trials
4.4 Trial Type wise Perennial Allergic Rhinitis Clinical Trials

5. Perennial Allergic Rhinitis Average Enrollment Trends
5.1 Average Enrollment in Perennial Allergic Rhinitis Trials by Year
5.2 Average Enrollment in Perennial Allergic Rhinitis Trials by Phase
5.3 Average Enrollment in Perennial Allergic Rhinitis Trials by Status
5.4 Average Enrollment in Perennial Allergic Rhinitis Trials by Type of Trial

6. Companies Participating in Perennial Allergic Rhinitis Clinical Trials
6.1 Perennial Allergic Rhinitis Trials by Sponsor Type
6.2 Perennial Allergic Rhinitis Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7. Trial Snapshots- Phase, Type, Title, Location, Start Year, Completion Year, Recruitment Status, Enrollment, Participating Countries, Trial Locations, Company, Drugs and Other Details
7.1 Perennial Allergic Rhinitis Trials- Phase 1
7.2 Perennial Allergic Rhinitis Trials- Phase 2
7.3 Perennial Allergic Rhinitis Trials- Phase 3
7.4 Perennial Allergic Rhinitis Trials- Phase 4

8. Appendix
8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List of Figures
Figure 1: Perennial Allergic Rhinitis Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific - Country wise Perennial Allergic Rhinitis Clinical Trials and Enrolment
Figure 5: Europe - Country wise Perennial Allergic Rhinitis Clinical Trials and Enrolment
Figure 6: Middle East Africa - Country wise Perennial Allergic Rhinitis Clinical Trials and Enrolment
Figure 7: North America - Country wise Perennial Allergic Rhinitis Clinical Trials and Enrolment
Figure 8: South and Central America - Country wise Perennial Allergic Rhinitis Clinical Trials and Enrolment
Figure 9: Perennial Allergic Rhinitis Clinical Trials by Phase
Figure 10: Perennial Allergic Rhinitis Clinical Trials by Trial Status
Figure 11: Perennial Allergic Rhinitis Clinical Trials by Type
Figure 12: Perennial Allergic Rhinitis Clinical Trials by Sponsor Type
Figure 13: Perennial Allergic Rhinitis Clinical Trials by Leading Sponsors
Figure 14: Perennial Allergic Rhinitis Average Enrollment by Phase
Figure 15: Perennial Allergic Rhinitis Average Enrollment by Trial Status
Figure 16: Perennial Allergic Rhinitis Average Enrollment by Type
Figure 17: Perennial Allergic Rhinitis- Average Enrolment by Type of Sponsors
Figure 18: Perennial Allergic Rhinitis- Enrolment by Leading Sponsors
Figure 19: Research Methodology

List of Tables
Table 1: Perennial Allergic Rhinitis Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific - Country wise Perennial Allergic Rhinitis Clinical Trials and Enrolment
Table 5: Europe - Country wise Perennial Allergic Rhinitis Clinical Trials and Enrolment
Table 6: Middle East Africa - Country wise Perennial Allergic Rhinitis Clinical Trials and Enrolment
Table 7: North America - Country wise Perennial Allergic Rhinitis Clinical Trials and Enrolment
Table 8: South and Central America - Country wise Perennial Allergic Rhinitis Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Perennial Allergic Rhinitis Average Enrollment by Phase
Table 15: Perennial Allergic Rhinitis Average Enrollment by Trial Status
Table 16: Perennial Allergic Rhinitis Average Enrollment by Type
Table 17: Perennial Allergic Rhinitis- Average Enrolment by Type of Sponsors
Table 18: Perennial Allergic Rhinitis- Enrolment by Leading Sponsors
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • AstraZeneca Plc
  • Cipla Ltd
  • Dr. Reddy's Laboratories Ltd
  • GlaxoSmithKline Plc
  • Glenmark Pharmaceuticals Ltd
  • Merck & Co Inc
  • Novartis AG
  • Sanofi
  • Teva Pharmaceutical Industries Ltd
  • UCB SA
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Order Online - visit: https://www.researchandmarkets.com/reports/4768067
Adroll
adroll